Salvador Aznar Benitah receives the “Premio Fundación Carmen y Severo Ochoa 2019” Blog Post

Salvador Aznar Benitah, ICREA at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, as received the “Premio Carmen y Severo Ochoa de Investigación en Biología Molecular” in acknowledgement of his work on adult stem cells and the relation of these with circadian rhythms and metastasis, and also in recognition of his recent entrepreneurial activity as co-founder of Ona Therapeutics.

 

IBEC presents its capabilities in 3D bioprinting at the 4th edition of INDUSTRY Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, participated in the fourth edition of INDUSTRY From Needs to Solutions, which took place from 29th to 31st October at Fira Barcelona´s Gran Via venue. The event brought together more than 150 companies in its exhibition area and 150 speakers within the framework of Barcelona Industry Week, that brought together seven major events related to digital transformation at Fira Barcelona. IoT Solutions World Congress, Blockchain Solutions World and AI & Cognitive Systems Forum were other events that added to this great summit where the achievements and innovations of disruptive technologies in the field of health became evident.

 

Scientists build machine learning-based algorithm to predict which cancer patients benefit from immunotherapy Blog Post

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, in collaboration with the Centre for Genomic Regulation (CRG) and Radboud University, have built a tool that detects genetic mutations that trigger the immune system, helping identify which cancer patients are more likely to benefit from immunotherapy. The algorithm also reveals which people living with hereditary diseases may benefit from drugs that already exist. The new technology’s potential is described today in Nature Genetics.

 

The biotechnology company Aromics has been recognized as one of the most innovative Biotecs at the Sino-Europe Healthtech Innovation Week in China Blog Post

The Horizon 2020 project BERMES aimed to develop a novel therapy for malignant mesothelioma, lead by the catalan biotech company Aromics, was recognized as one of the most innovative initiatives at the Sino-Europe Innovation Week of Health Technology which was held from 12th to 16th October at two of the most technological and powerful cities in China: Nanjing and Shanghai. The biotechnology company, located at the Barcelona Science Park, participated in the event as part of a mission organized by the BioRegion of Catalonia to explore new opportunities for collaboration with Chinese companies and institutions and to learn about the experience of other European clusters in the Asian giant.

 

Molomics opens an investment round to accelerate an innovative project against Parkinson’s Blog Post

Molomics Biotech, based in the Barcelona Science Park, has just opened a financing round of 400,000 euros through the online investment platform Capital Cell, allowing also small private investors to acquire shares of the company. With this capital increase, the Spanish startup –which has a financial and professional support of the Michael J. Fox Foundation wants to enter the preclinical phase with an innovative treatment to fight involuntary movements (dyskinesias) associated with Parkinson’s.

 

New Born Solutions chosen to take part in the EIT Health Digital Sandbox Blog Post

New Born Solutions, based in the Barcelona Science Park (PCB), was one of the 10 small and medium-sized enterprises chosen to take part in the Digital Sandbox accelerator programme developed by EIT Health, the Knowledge and Innovation in Health Community, promoted by the European Institute of Innovation & Technology (EIT). The winning start-ups, chosen from around thirty applicants from all over Europe, will receive advisory services and up to €35,000 in funding to develop products and services making use of the data available on biobanks and quality registers in Europe.

 

IBEC obtains a second accreditation as Severo Ochoa Centre of Excellence Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, is one of the six centres in Spain to be awarded accreditation in this round of the Severo Ochoa Excellence programme. Furthermore, IBEC is the only center that receives this accreditation for the second time. The awards last for four years and bring a million euros each year to the winning centres, it also implies strengthening research capacities and boosting success rates in other competitive funding programmes.

 

Rob Surgical, a spin-off from IBEC and UPC, closes a €5 million investment round Blog Post

Rob Surgical, a spin-off created by the Institute for Bioengineering of Catalonia (IBEC), based in the PCB, and the Polytechnic University of Catalonia (UPC) in 2012, has closed a €5 million investment round with the Dutch holding Scranton Enterprises to fund the final phase of the new Bitrack System –an alternative to the current laparoscopy surgical robot Da Vinci– and launch the product onto the market.

 

The sequence of the almond tree and peach tree genomes will be key tools in their genetic improvement and adaptation to climate change Blog Post

An international team led by researchers of the Centre for Research in Agricultural Genomics (CRAG) in conjunction with Tyler Alioto of the Centre Nacional d’Anàlisi Genòmica (CNAG-CRG) –based in PCB and part of the Centre for Genomic Regulation (CRG)– has sequenced the genome of the almond tree and compared it to that of its closest relative, the peach tree. The results provide some unique insights into the recent evolution of both species and will be key tools in their genetic improvement, including the eradication of bitter almonds, fruit quality and adaptation to climate change.

 

DD BioLab strengthens its leadership in the Spanish biotechnology sector Blog Post

The acquisition of Cultek and Teknovas by the Dutscher Group, the leading independent distributor of laboratory supplies in Europe, its Spanish subsidiary, DD BioLab, as the leading supplier in Spain of scientific instruments, consumables and laboratory equipment for research in biotechnology and health. Since it was established in Barcelona Science Park in 2014, DD BioLab has registered sustained 39% annual growth. In 2018, its turnover was around €5M and it expects to exceed €10M in 2022.